- Home
- YGMZ vs EVOK Comparison
YGMZ vs EVOK Comparison
Compare YGMZ & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YGMZ
- EVOK
- Stock Information
- Founded
- YGMZ 2002
- EVOK 2007
- Country
- YGMZ China
- EVOK United States
- Employees
- YGMZ N/A
- EVOK N/A
- Industry
- YGMZ Transportation Services
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- YGMZ Consumer Discretionary
- EVOK Health Care
- Exchange
- YGMZ Nasdaq
- EVOK Nasdaq
- Market Cap
- YGMZ 7.5M
- EVOK 7.0M
- IPO Year
- YGMZ 2020
- EVOK 2013
- Fundamental
- Price
- YGMZ $1.03
- EVOK $4.54
- Analyst Decision
- YGMZ
- EVOK
- Analyst Count
- YGMZ 0
- EVOK 0
- Target Price
- YGMZ N/A
- EVOK N/A
- AVG Volume (30 Days)
- YGMZ 19.5K
- EVOK 23.6K
- Earning Date
- YGMZ 01-01-0001
- EVOK 11-07-2024
- Dividend Yield
- YGMZ N/A
- EVOK N/A
- EPS Growth
- YGMZ N/A
- EVOK N/A
- EPS
- YGMZ N/A
- EVOK N/A
- Revenue
- YGMZ $89,002,243.00
- EVOK $8,617,036.00
- Revenue This Year
- YGMZ N/A
- EVOK $97.35
- Revenue Next Year
- YGMZ N/A
- EVOK $99.52
- P/E Ratio
- YGMZ $14.50
- EVOK N/A
- Revenue Growth
- YGMZ N/A
- EVOK 100.35
- 52 Week Low
- YGMZ $0.91
- EVOK $3.54
- 52 Week High
- YGMZ $6.24
- EVOK $14.40
- Technical
- Relative Strength Index (RSI)
- YGMZ 35.59
- EVOK 48.42
- Support Level
- YGMZ $1.04
- EVOK $4.42
- Resistance Level
- YGMZ $1.25
- EVOK $4.49
- Average True Range (ATR)
- YGMZ 0.09
- EVOK 0.28
- MACD
- YGMZ 0.00
- EVOK 0.07
- Stochastic Oscillator
- YGMZ 8.33
- EVOK 64.00
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.